Abstract
Recent philosophical literature has highlighted the complexities of handling dissent in science. On one hand, scientific dissent can be very harmful, as when “merchants of doubt” strategically appeal to dissent in order to undermine important environmental and public-health initiatives. On the other hand, scientific dissent can also be beneficial when it helps to promote scientific objectivity, progress, and public engagement. Some authors have responded to this tension by suggesting criteria for distinguishing normatively appropriate and inappropriate dissent, while other authors have suggested that it is more fruitful to alter the social context in which science operates in order to alleviate the negative effects of dissent over the long term. This paper proposes another approach that may be helpful for managing particularly challenging cases of scientific dissent. It argues that instances of scientific dissent often incorporate debates over value judgments, so many difficult cases of dissent can be navigated by: (1) identifying and highlighting those value judgments; and (2) managing those value judgments by drawing strategies from the extensive literature on values and science. The paper illustrates this approach by examining a case study of dissent over the treatment of long-term symptoms associated with Lyme disease.
Similar content being viewed by others
Notes
Throughout this paper, I will typically refer to “appropriate” and “inappropriate” dissent rather than using Biddle and Leuschner’s language of “epistemically detrimental” dissent. I think it is at least possible that dissent could be inappropriate for reasons other than being epistemically detrimental, and dissent could potentially be appropriate in some cases even if it is epistemically detrimental. See also de Melo-Martín and Intemann’s (2018) concept of “normatively inappropriate dissent.”
References
Alexandrova, A. (2018). Can the science of well-being be objective? British Journal for the Philosophy of Science, 69, pp. 421–445.
Auwaerter, P. G., Bakken, J. S., Dattwyler, R. J., Dumler, J. S., Halperin, J. J., McSweegan, E., Nadelman, R. B., O’Connell, S., Shapiro, E. D., Sood, S. K., Steere, A. C., Weinstein, A., & Wormser, G. P. (2011a). Antiscience and ethical concerns associated with advocacy of Lyme disease. The Lancet Infectious Diseases, 11, pp. 713–719.
Auwaerter, P. G., Bakken, J. S., Dattwyler, R. J., Dumler, J. S., Halperin, J. J., McSweegan, E., Nadelman, R. B., O’Connell, S., Sood, S. K., Weinstein, A., & Wormser, G. P. (2011b). Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism. Journal of Medical Ethics, 37, pp. 68–73.
Berndtson, K. (2013). Review of evidence for immune evasion and persistent infection in Lyme disease. International Journal of General Medicine, 291–306.
Biddle, J., & Leuschner, A. (2015). Climate skepticism and the manufacture of doubt: Can dissent in science be epistemically detrimental? European Journal for Philosophy of Science, 5, pp. 261–278.
Boykoff, M., & Boykoff, J. (2004). Balance as bias: Global warming and the U.S. Prestige Press. Global Environmental Change, 14, pp. 125–136.
Corburn, J. (2005). Street science: Community knowledge and environmental health justice. MIT Press.
de Melo-Martín, I., & Intemann, K. (2014). Who’s afraid of dissent? Addressing concerns about undermining scientific consensus in public policy developments. Perspectives on Science, 22(4), pp. 593–615.
de Melo-Martín, I., & Intemann, K. (2018). The fight against doubt: How to Bridge the gap between scientists and the public. Oxford University Press.
DeLong, A. K., Blossom, B., Maloney, E. L., & Phillips, S. E. (2012). Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials. Contemporary Clinical Trials, 33, pp. 1132–1142.
DiMarco, M., & Khalifa, K. (2019). Inquiry tickets: values, pursuit, and underdetermination. Philosophy of Science, 86, pp. 1016–1028.
Douglas, H. (2005). Inserting the Public into Science. In S. Maasen & P. Weingart (Eds.), Democratization of expertise? Exploring novel forms of scientific advice in political decision-making (pp. 153–169). Springer.
Douglas, H. (2008). The role of values in expert reasoning. Public Affairs Quarterly, 22, pp. 1–18.
Douglas, H. (2014). The moral terrain of science. Erkenntnis, 79, pp. 961–979.
Dumes, A. A. (2020). Divided bodies: Lyme disease, contested illness, and evidence-based medicine. Duke University Press.
Elliott, K. (2011). Is a little pollution good for you? Incorporating societal values in environmental research. Oxford University Press.
Elliott, K. (2017). A tapestry of values: An introduction to values in science. Oxford University Press.
Elliott, K. C. (2019). Science journalism, value judgments, and the open science movement. Frontiers in Communication, 4, 71.
Elliott, K. (2022a). A taxonomy of transparency in science. Canadian Journal of Philosophy, 52, pp. 342–355.
Elliott, K. (2022b). Values in Science. Cambridge University Press.
Elliott, K., & McKaughan, D. J. (2014). Nonepistemic values and the multiple goals of science. Philosophy of Science, 81, pp. 1–21.
Elliott, K., & Resnik, D. B. (2014). Science, policy, and the transparency of values. Environmental Health Perspectives, 122, pp. 647–650.
Elliott, K., & Willmes, D. (2013). Cognitive attitudes and values in science. Philosophy of Science, 80(5), pp. 807–817.
Fallon, B. A., & Sotsky, J. (2017). Conquering Lyme disease: Science bridges the great divide. Columbia University Press.
Fallon, B. A., Keilp, J. G., Corbera, K. M., et al. (2008). A randomized, placebo-controlled trial of repeated iv antibiotic therapy for Lyme encephalopathy. Neurology, 70, pp. 992–1003.
Fernández Pinto, M., & Hicks, D. J. (2019). Legitimizing values in regulatory science. Environmental Health Perspectives, 127, p. 035001.
Firestein, S. (2012). Ignorance: How It drives science. Oxford University Press.
Fleming, N. (2020). Coronavirus misinformation, and how scientists can help to fight it. Nature, 583, pp. 155–156.
Franco, P. L. (2017). Assertion, nonepistemic values, and scientific practice. Philosophy of Science, 84, pp. 160–180.
Godler, Y., Reich, Z., & Miller, B. (2020). Social epistemology as a new paradigm for journalism and media studies. New Media and Society, 22, pp. 213–229.
Goldenberg, M. (2021). Vaccine hesitancy: Public trust, expertise, and the war on science. University of Pittsburgh Press.
Halpern, M., & Elliott, K. (2022). Science as experience: A deweyan model of science communication. Perspectives on Science, 30, pp. 621–656.
Harker, D. (2015). Creating scientific controversies: Uncertainty and bias in science and society. Cambridge University Press.
Harvard, S., & Werker, G. (2021). Health economists on involving patients in modeling: Potential benefits, harms, and variables of interest. PharmacoEconomics, 39, pp. 823–833.
Harvard, S., & Winsberg, E. (2022). The epistemic risk in representation. Kennedy Institute of Ethics Journal, 32(1), 1–31.
Hicks, D. J. (2017). Scientific controversies as proxy politics. Issues in Science and Technology, 33, p. 67.
Holman, B., & Elliott, K. C. (2018). The promise and perils of industry-funded science. Philosophy Compass, 13, p. e12544.
Holman, B., & Wilholt, T. (2022). The new demarcation problem. Studies in History and Philosophy of Science, 91, pp. 211–220.
Horel, S. and Foucart, S. (2020). Endocrine disruptors in Europe: Nineteen “Experts” are polluting the debate. Environmental Health News, June 23. Retrieved August 23, 2023 from https://www.ehn.org/european-parliament-endocrine-disruptors-2646227143.html
ILADS. (2020). Controversies and challenges in treating Lyme and other tick-borne diseases. https://www.ilads.org/research-literature/controversies-challenges/. Accessed 19 Oct 2023.
Intemann, K. (2015). Distinguishing between legitimate and illegitimate values in climate modeling. European Journal for Philosophy of Science., 5, pp. 217–232.
John, S. (2019). Science, truth, and dictatorship: Wishful thinking or wishful speaking? Studies in History and Philosophy of Science, 78, pp. 64–72.
Johnson, L., & Stricker, R. B. (2009). Attorney general forces infectious diseases society of America to Redo Lyme guidelines due to flawed development process. Journal of Medical Ethics, 35, pp. 283–288.
Klempner, M. S., Hu, L. T., Evans, J., Schmid, C. H., Johnson, G. M., Trevino, R. P., Norton, D., Levy, L., Wall, D., McCall, J., & Kosinski, M. (2001). Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine, 345(2), 85–92.
Kourany, J. (2018). Adding to the tapestry. Philosophy, Theory, and Practice in Biology, 10, p. 9.
Krupp, L. B., Hyman, L. G., Grimson, R., et al. (2003). Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology, 60, pp. 1923–1930.
Kuhn, T. (1977). Objectivity, value judgement, and theory choice. In T. Kuhn (Ed.), The essential tension (pp. 320–329). University of Chicago Press.
Lacey, H. (2017). Distinguishing between cognitive and social values. In K. Elliott & D. Steel (Eds.), Current Controversies in Values and Science (pp. 15–30). Routledge.
Lantos, P. M. (2011). Chronic Lyme disease: The controversies and the science. Expert Review of Anti-Infective Therapy, 9, pp. 787–797.
Lantos, P. M., Rumbaugh, J., Bockenstedt, L. K., Falck-Ytter, Y. T., Aguero-Rosenfeld, M. E., Auwaerter, P. G., Baldwin, K., Bannuru, R. R., Belani, K. K., Bowie, W. R., Branda, J. A., et al. (2021). Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of lyme disease. Arthritis & Rheumatology, 73, pp. 12–20.
Le Bihan, S., & Amadi, I. (2017). On epistemically detrimental dissent: contingent enabling factors versus stable difference-makers. Philosophy of Science, 84, pp. 1020–1030.
Leuschner, A., & Fernández Pinto, M. (2021). How dissent on gender bias in academia affects science and society: Learning from the case of climate change denial. Philosophy of Science, 88, pp. 573–593.
Leuschner, A., & Fernández Pinto, M. (2022). Exploring the limits of dissent: The case of shooting bias. Synthese, 200, pp. 1–19.
Longino, H. (1990). Science as social knowledge. Princeton University Press.
Longino, H. (2002). The Fate of Knowledge. Princeton University Press.
Ludwig, D. (2016). Ontological choices and the value-free ideal. Erkenntnis, 81, pp. 1253–1272.
Lusk, G., & Elliott, K. (2022). Non-epistemic values and scientific assessment: an adequacy-for-purpose view. European Journal for Philosophy of Science, 12, p. 35.
Maloney, E. L. (2016). Controversies in persistent (chronic) Lyme disease. Journal of Infusion Nursing, 39, pp. 369–375.
McGarity, T., & Wagner, W. (2008). Bending science: How special interests corrupt public health research. Harvard University Press.
McIlroy-Young, B., Öberg, G., & Leopold, A. (2021). The manufacturing of consensus: The struggle for epistemic authority in chemical risk evaluation. Environmental Science and Policy, 122, pp. 25–34.
McKaughan, D. J., & Elliott, K. C. (2015). Introduction: Cognitive attitudes and values in science. Studies in History and Philosophy of Science, 53, pp. 57–61.
Michaels, D. (2008). Doubt Is Their Product: How Industry’s Assault on Science Threatens Your Health. Oxford University Press.
Miller, B. (2013). When is consensus knowledge based? Distinguishing shared knowledge from mere agreement. Synthese, 190, pp. 1293–1316.
Miller, B. (2014). Catching the WAVE: The weight-adjusting account of values and evidence. Studies in History and Philosophy of Science, 47, pp. 69–80.
Miller, B. (2021). When is scientific dissent epistemically inappropriate? Philosophy of Science, 88, pp. 918–928.
Miller, B., & Pinto, M. (2022). Epistemic equality: Distributive epistemic justice in the context of justification. Kennedy Institute of Ethics Journal, 32, pp. 173–203.
NIH (National Institutes of Health). (2018). Lyme disease antibiotic treatment research. Retrieved October 1, 2022 from https://www.niaid.nih.gov/diseases-conditions/lyme-disease-antibiotic-treatment-research
O’Connor, C., & Weatherall, J. (2019). The Misinformation Age. Yale University Press.
Oreskes, N. (2019). Why Trust Science? Princeton University Press.
Oreskes, N., & Conway, E. (2010). Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming. Bloomsbury.
Orman, N. (2021). AAAS Voices: Countering Science Misinformation. Retrieved February 19, 2023. https://www.aaas.org/news/misinformation?utm_campaign=Gadi&utm_source=AAAS&utm_medium=Twitter
Ottinger, G., & Cohen, B. (2011). Technoscience and environmental justice: Expert cultures in a grassroots movement. MIT Press.
Pfeiffer, M. B. (2018). Lyme: The first epidemic of climate change. Island Press.
Popper, K. (1963). Conjectures and refutations: The growth of scientific knowledge. Routledge.
Proctor, R. (2011). Golden holocaust: Origins of the cigarette catastrophe and the case for abolition. University of California Press.
Resnik, D. B., & Elliott, K. C. (2019). Value-entanglement and the integrity of scientific research. Studies in History and Philosophy of Science Part A, 75, pp. 1–11.
Rolin, K. (2017). Scientific dissent and a fair distribution of epistemic responsibility. Public Affairs Quarterly, 31, pp. 209–230.
Schroeder, S. A. (2021). Democratic values: A better foundation for public trust in science. British Journal for the Philosophy of Science. https://doi.org/10.1093/bjps/axz023
Stanek, G., Wormser, G. P., Gray, J., & Strle, F. (2012). Lyme borreliosis. The Lancet, 379(9814), 461–473.
Stanev, R. (2017). Inductive Risk and Values in Composite Outcome Measures. In K. C. Elliott & T. Richards (Eds.), Exploring inductive risk: Case studies of values in science (pp. 171–191). Oxford University Press.
Thacker, P. (2021). The covid-19 lab leak hypothesis: Did the media fall victim to a misinformation campaign? BMJ, 374, p. 1656.
Woodward, J. (2010). Causation and biology: Stability, specificity, and the choice of levels of explanation. Biology and Philosophy, 25, pp. 287–318.
World Health Organization. (2021). Fighting misinformation about COVID-19, one click at a time. Retrieved February 19, 2023 from https://www.who.int/news-room/feature-stories/detail/fighting-misinformation-in-the-time-of-covid-19-one-click-at-a-time
Acknowledgements
I am very grateful for excellent suggestions I received on this paper from two anonymous reviewers for this journal. I also received helpful feedback from audiences at the workshop on Values in Science and Political Philosophy at Claremont McKenna College, the workshop on Engaging Ethics and Epistemology of Science at Leibniz Universität Hannover, the workshop on The Legacy of the Value-Free Ideal of Science at Uppsala University, and a reading group based at the Université de Montréal and the University of Calgary. Finally, I thank Philippe Stamenkovic and Adam Tamas Tuboly for their invitation to contribute to this collection of articles.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has received compensation for a lecture on ethics for the Chlorine Institute, an industry trade association focused on safety and sustainability in the chlor-alkali industry. The author acknowledges that this could possibly affect his judgment about how to handle dissent in science, specifically in cases where industry is involved.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Elliott, K.C. Navigating dissent by managing value judgments: the case of Lyme disease. Synthese 202, 134 (2023). https://doi.org/10.1007/s11229-023-04368-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11229-023-04368-z